UK’s ARIA Targets Brain Circuitry to Cure Intractable Neurological Disorders

This initiative shifts the focus from broad pharmacological interventions to precision-engineered neurotechnologies that target specific malfunctioning brain circuits. By treating neurological conditions as structural wiring issues, ARIA aims to unlock platform technologies capable of addressing diverse disorders ranging from Alzheimer's to addiction.